In another aspect, the invention provides co-crystals of the formula (VX-950)m:(CCF)n, wherein CCF is a co-crystal former selected from the group consisting of salicylic acid, 4-amino salicylic acid, and oxalic acid; and m and n, independently, are an integer of 1 to 5.